HISTOLOGY AND HISTOPATHOLOGY

Cellular and Molecular Biology

 

Expression of integrins αvß3 and αvß5 and their ligands in primary and secondary central nervous system neoplasms

Michel Mittelbronn1, Arne Warth2, Richard Meyermann3, Simon Goodman4 and Michael Weller5

3Institute of Brain Research, University of Tübingen, Tübingen, Germany, 1Neurological Institute (Edinger Institute), Goethe-University, Frankfurt/Main, Germany, 2Institute of Pathology, University of Heidelberg, Heidelberg, Germany, 4Therapeutic Area Oncology, Merck KGaA, Darmstadt, Germany and 5Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

Offprint requests to: Michel Mittelbronn, Goethe-University Frankfurt, Institute of Neurology (Edinger Institute), Heinrich-Hoffmann-Str. 7, 60528 Frankfurt/Main, Germany. e-mail: michel.mittelbronn@kgu.de


Summary. Aims: To study the expression of integrins αvß3 and αvß5 and their ligands in tumour, stroma and endothelial cells from human glioblastoma and CNS metastases from breast, lung and skin tumours. Methods and results: Integrin and integrin ligand expression was quantified in frozen tumour surgical specimens (15 glioblastomas and breast carcinoma metastases as well as 16 lung carcinoma and melanoma metastases) using immunohistochemistry. Gene expression profiles were evaluated in glioblastomas (n=424) and in normal brain (n=11). Overall, αvß3 expression was more common than αvß5, except in tumours derived from lung. αvß3 expression was most frequent in glioblastomas and melanoma metastases. Most lung-derived tumours expressed αvß5, but expression was less frequent in other tumours; about 20% of breast-derived tumours strongly expressed αvß5. Melanoma-derived tumours did not express αvß5. Expression of integrin ligands vitronectin, fibrinogen, fibronectin and osteopontin was variable between tumours, although most tumours expressed the ligands to some extent. Marked αvß3, but not αvß5, expression was common in stroma of CNS metastases. In blood vessels, αvß3 expression was more frequent than αvß5 and more pronounced in CNS metastases than in glioblastomas. Integrin ligand expression occurred in blood vessels in most tumours. In glioblastomas, mRNA expression of αvß3, αvß5, osteopontin and fibronectin were significantly upregulated over normal brain. Conclusions: Overall, we report distinct and heterogeneous patterns of integrin expression in primary and secondary brain tumours that may be relevant to the future development of integrin-targeting therapeutic approaches to brain tumours
. Histol Histopathol 28, 749-758 (2013)

Key words: Cancer, Integrin expression, Tumour microenvironment

DOI: 10.14670/HH-28.749